Research is exploring the connection between the microbiome and immunotherapy, particularly in relation to immune checkpoint inhibitors. This area of study may involve various approaches, including a translational framework for perioperative immunoengineering. The investigation aims to uncover hidden predictors and potentially improve outcomes in immunotherapy.